Coherus Biosciences | CHRS - Ebit





Ebit Changement Date
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.83B 130M 2026-03
Baxter International USD 66M 280.2M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Fujifilm JPY 89.96B 6.77B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD -1.88B 8.12B 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xencor USD -53.63M 6.11M 2025-12
Zoetis USD 835M 140M 2025-12